Perceptive Advisors Turns Big Loss into Hefty Gain

Joseph Edelman’s biotech fund, whose performance landed him on the Rich List last year, was down by double digits this year but has since bounced back and then some.

October 6, 2016


	Joseph Edelman, Perceptive Advisors (Bloomberg)

Now, this is what you call a comeback.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Perceptive Advisors Joseph Edelman

Premium

April 25, 2019

Premium

January 23, 2018